| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 100/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Sorafenib Tosylate |
| Cas number | 475207-59-1 |
| Appearance | White powder |
| MF | C28H24ClF3N4O6S |
| MW | 637.02657 |
Sorafenib is a new multi-targeted oral drug for the treatment of tumors. Its primary development goal is to treat gastrointestinal stromal tumors and metastatic kidney cells that are not responsive or unbearable to standard therapies.
Sorafenib can selectively target certain proteins of the receptor, which is considered plays a role in molecular switching in the tumor growth process. Its indications have been in the approval by the FDA United States.
1. Sorafenib tosylate is commonly used as a potent RAF kinase inhibitor.
2. Sorafenib tosylate is also used as antineoplastic drug.
3. Sorafenib is used to treat liver tumor cells that can not be surgically or distantly metastasized
4. Sorafenib is used to treat neovascular tumors that can not be operated
5. Sorafenib is used to treat radioactive iodine therapy is no longer effective local recurrence or metastasis, progressive differentiation of thyroid patients.
){kind=link}